Passage BIO (PASG) Capital Expenditures (2019 - 2024)
Passage BIO's Capital Expenditures came in at $14,000 for Q4 2024, up 7.7% from $13,000 a year earlier.
Powered by 
Analysis
Passage BIO (PASG) Capital Expenditures (2019 - 2024) Analysis & Trends
For FY2024, Passage BIO's Capital Expenditures was $34,000, down 76.7% from FY2023.
- Capital Expenditures has declined in each of the last three years, with a five-year compound annual growth rate of -50.9% (FY2019 to FY2024).
- Going back by year, Capital Expenditures was $146,000 in FY2023 (-93.6%), $2.27 million in FY2022 (-87.1%), $17.64 million in FY2021 and $1.15 million in FY2020 (-3.9%).
- The Q4 2024 figure represents the highest quarterly Capital Expenditures since Q2 2023.
- Year-over-year, Capital Expenditures increased in 1 of the last five quarters, with an average decline of 74.4%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2021 (growth of 748.1%), and the weakest in Q3 2023 (a decline of 98.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Passage BIO | 14.48 Mn | 14.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 26,000.00 |
| Dec 31, 2022 | 474,000.00 |
| Sep 30, 2022 | 244,000.00 |
| Jun 30, 2022 | 831,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 6.82 Mn |
| Sep 30, 2021 | 6.01 Mn |
| Jun 30, 2021 | 4.01 Mn |
| Mar 31, 2021 | 801,000.00 |
| Dec 31, 2020 | 804,000.00 |
| Sep 30, 2020 | 149,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Mar 31, 2020 | 99,000.00 |
| Dec 31, 2019 | 43,000.00 |
| Sep 30, 2019 | 109,000.00 |
| Jun 30, 2019 | 157,000.00 |
API Access
Passage BIO Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PASG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PASG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PASG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();